Active Ingredient (In Each Tablet)
Loratadine USP, 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by Medline Industries, Inc. for the product Loratadine (NDC 53329-651). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Loratadine USP, 10 mg
Antihistamine
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
If you have ever had an allergic reaction to this product or any of its ingredients.
Liver or kidney disease. Your doctor should determine if you need a different dose.
Do not take more than directed. Taking more than directed may cause drowsiness.
An allergic reaction to this product occurs. Seek medical help right away.
Ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
Corn starch, lactose monohydrate, magnesium stearate, pregelatinized starch
Call 1-800-MEDLINE (633-5463), Monday - Friday, 9AM - 5PM CST
MEDLINE
NDC 53329-651-33
†Compare to the active ingredient in Claritin®
NON-DROWSY*
LORATADINE TABLETS, USP 10 mg
ANTIHISTAMINE
ALLERGY RELIEF
Indoor & Outdoor Allergies
24 HOUR RELIEF of:
• Sneezing
• Runny Nose
• Itchy, Watery Eyes
• Itchy Throat or Nose
10 mg
30 Tablets
(When taken as directed. See Drug Facts Panel.)
Distributed by: Medline, Industries, Inc.
5099016/1012
* Please review the disclaimer below.